These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 8818855)

  • 1. Paediatric safety of azithromycin: worldwide experience.
    Treadway G; Pontani D
    J Antimicrob Chemother; 1996 Jun; 37 Suppl C():143-9. PubMed ID: 8818855
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Azithromycin. A review of its use in paediatric infectious diseases.
    Langtry HD; Balfour JA
    Drugs; 1998 Aug; 56(2):273-97. PubMed ID: 9711451
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tolerability of 3-day, once-daily azithromycin suspension versus standard treatments for community-acquired paediatric infectious diseases.
    Treadway G; Reisman A
    Int J Antimicrob Agents; 2001 Nov; 18(5):427-31. PubMed ID: 11711256
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An open, multicentre, comparative study of the efficacy and safety of azithromycin and co-amoxiclav in the treatment of upper and lower respiratory tract infections in children. The Paediatric Azithromycin Study Group.
    Lauvau DV; Verbist L
    J Int Med Res; 1997; 25(5):285-95. PubMed ID: 9364291
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The safety of azithromycin in the treatment of adults with community-acquired respiratory tract infections.
    Treadway G; Pontani D; Reisman A
    Int J Antimicrob Agents; 2002 Mar; 19(3):189-94. PubMed ID: 11932140
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An open study to compare azithromycin with cefaclor in the treatment of children with acute otitis media.
    Rodriguez AF
    J Antimicrob Chemother; 1996 Jun; 37 Suppl C():63-9. PubMed ID: 8818847
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparative study of the efficacy, safety and tolerability of azithromycin and cefaclor in the treatment of children with acute skin and/or soft tissue infections.
    Montero L
    J Antimicrob Chemother; 1996 Jun; 37 Suppl C():125-31. PubMed ID: 8818853
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical safety and tolerance of azithromycin in children.
    Hopkins S
    J Antimicrob Chemother; 1993 Jun; 31 Suppl E():111-7. PubMed ID: 8396082
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomized, double-blind study of the clinical efficacy of 3 days of azithromycin compared with co-amoxiclav for the treatment of acute otitis media.
    Dunne MW; Latiolais T; Lewis B; Pistorius B; Bottenfield G; Moore WH; Garrett A; Stewart TD; Aoki J; Spiegel C; Boettger D; Shemer A
    J Antimicrob Chemother; 2003 Sep; 52(3):469-72. PubMed ID: 12888586
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multicentre evaluation of azithromycin in comparison with co-amoxiclav for the treatment of acute otitis media in children.
    Schaad UB
    J Antimicrob Chemother; 1993 Jun; 31 Suppl E():81-8. PubMed ID: 8396101
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomized, comparative study to evaluate the efficacy and tolerability of a 3-day course of azithromycin versus a 10-day course of co-amoxiclav as treatment of adult patients with lower respiratory tract infections.
    Zachariah J
    J Antimicrob Chemother; 1996 Jun; 37 Suppl C():103-13. PubMed ID: 8818851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Concentrations of azithromycin in tonsilar and/or adenoid tissue from paediatric patients.
    Vaudaux BP; Cherpillod J; Dayer P
    J Antimicrob Chemother; 1996 Jun; 37 Suppl C():45-51. PubMed ID: 8818845
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative tolerability of erythromycin and newer macrolide antibacterials in paediatric patients.
    Principi N; Esposito S
    Drug Saf; 1999 Jan; 20(1):25-41. PubMed ID: 9935275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Once-daily, 3-day azithromycin versus a three-times-daily, 10-day course of co-amoxiclav in the treatment of adults with lower respiratory tract infections: results of a randomized, double-blind comparative study.
    Gris P
    J Antimicrob Chemother; 1996 Jun; 37 Suppl C():93-101. PubMed ID: 8818850
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An open comparative study of azithromycin and roxithromycin in the treatment of acute upper respiratory tract infections.
    Müller O
    J Antimicrob Chemother; 1996 Jun; 37 Suppl C():83-92. PubMed ID: 8818849
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparative study of azithromycin and amoxycillin in paediatric patients with acute otitis media.
    Mohs E; Rodriguez-Solares A; Rivas E; el Hoshy Z
    J Antimicrob Chemother; 1993 Jun; 31 Suppl E():73-9. PubMed ID: 8396100
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical safety of azithromycin].
    Higa F; Saito A
    Jpn J Antibiot; 2000 Jun; 53 Suppl B():125-35. PubMed ID: 12572096
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy, safety and tolerability of azithromycin versus roxithromycin in the treatment of acute lower respiratory tract infections.
    Laurent K
    J Antimicrob Chemother; 1996 Jun; 37 Suppl C():115-24. PubMed ID: 8818852
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of the efficacy, tolerability and safety of azithromycin and co-amoxiclav in the treatment of sinusitis in adults.
    Clement PA; de Gandt JB
    J Int Med Res; 1998; 26(2):66-75. PubMed ID: 9602984
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An open comparative study of azithromycin versus cefaclor in the treatment of patients with upper respiratory tract infections.
    O'Doherty B
    J Antimicrob Chemother; 1996 Jun; 37 Suppl C():71-81. PubMed ID: 8818848
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.